We are live on
!
Find out more
CSS
Cubist Systematic Strategies Portfolio holdings
AUM
$21B
1-Year Est. Return
21.48%
This Fund
S&P 500
This Quarter
Est. Return
+4.1%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.02%
AUM
$1.99B
AUM Growth
+$284M
(+17%)
Cap. Flow
+$258M
Cap. Flow
% of AUM
12.95%
Top 10 Holdings %
Top 10 Hldgs %
13.22%
Holding
2,248
New
441
Increased
650
Reduced
654
Closed
492
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SAGE
Sage Therapeutics
SAGE
|
+$11.9M |
| 2 |
Insulet
PODD
|
+$11.1M |
| 3 |
ZEN
ZENDESK INC
ZEN
|
+$10.8M |
| 4 |
PFPT
Proofpoint, Inc.
PFPT
|
+$10.7M |
| 5 |
GRUB
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
|
+$10.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$59.2M |
| 2 |
GoDaddy
GDDY
|
+$10.6M |
| 3 |
Palo Alto Networks
PANW
|
+$10.5M |
| 4 |
Citigroup
C
|
+$8.89M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$7.64M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.96% |
| 2 | Consumer Discretionary | 13.01% |
| 3 | Healthcare | 12.59% |
| 4 | Industrials | 12.57% |
| 5 | Financials | 11.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALDR
1001
DELISTED
Alder Biopharmaceuticals
ALDR
| $342K | 0.02% |
21,639
-5,975
| -22% | -$90.8K |
|
1002
IPG Photonics
IPGP
$3.89B
| $341K | 0.02% |
1,544
-2,840
| -65% | -$670K |
|
1003
Lexicon Pharmaceuticals
LXRX
$1.09B
| $341K | 0.02% |
28,405
+2,373
| +9% | +$24.3K |
|
1004
Tronox
TROX
$933M
| $341K | 0.02% |
17,311
-14,156
| -45% | -$264K |
|
1005
Methanex
MEOH
$4.02B
| $340K | 0.02% |
+4,815
| New | +$323K |
|
|
PDS
1006
Precision Drilling
PDS
$963M
| $340K | 0.02% |
5,130
-876
| -15% | -$58.8K |
|
1007
Adeia
ADEA
$3.3B
| $339K | 0.02% |
79,558
-32,001
| -29% | -$173K |
|
1008
Howmet Aerospace
HWM
$117B
| $339K | 0.02% |
26,017
+11,180
| +75% | +$166K |
|
1009
Universal Insurance Holdings
UVE
$1.23B
| $338K | 0.02% |
+9,633
| New | +$328K |
|
1010
Zumiez
ZUMZ
$330M
| $337K | 0.02% |
13,439
+4,997
| +59% | +$124K |
|
1011
Kroger
KR
$34.7B
| $336K | 0.02% |
11,801
-838
| -7% | -$21.1K |
|
1012
Federal Realty Investment Trust
FRT
$10.5B
| $335K | 0.02% |
2,648
-4,901
| -65% | -$578K |
|
|
PE
1013
DELISTED
PARSLEY ENERGY INC
PE
| $335K | 0.02% |
11,066
-4,356
| -28% | -$128K |
|
1014
Civeo
CVEO
$358M
| $334K | 0.02% |
6,382
-527
| -8% | -$23.9K |
|
|
PGTI
1015
DELISTED
PGT, Inc.
PGTI
| $334K | 0.02% |
+16,029
| New | +$313K |
|
1016
CNA Financial
CNA
$14.2B
| $333K | 0.02% |
7,300
-11,500
| -61% | -$556K |
|
1017
Fidelity National Financial
FNF
$13.8B
| $333K | 0.02% |
9,204
-33,206
| -78% | -$1.21M |
|
1018
UroGen Pharma
URGN
$2.26B
| $333K | 0.02% |
+6,694
| New | +$390K |
|
|
PVG
1019
DELISTED
PRETIUM RESOURCES INC.
PVG
| $333K | 0.02% |
45,344
-81,208
| -64% | -$579K |
|
1020
ACI Worldwide
ACIW
$5.88B
| $332K | 0.02% |
+13,449
| New | +$328K |
|
1021
Agree Realty
ADC
$9.46B
| $332K | 0.02% |
6,290
-767
| -11% | -$39.1K |
|
1022
Enova International
ENVA
$6.55B
| $332K | 0.02% |
+9,088
| New | +$276K |
|
1023
Coherus Oncology
CHRS
$224M
| $331K | 0.02% |
+23,643
| New | +$338K |
|
1024
Insight Enterprises
NSIT
$4.24B
| $331K | 0.02% |
+6,759
| New | +$291K |
|
1025
Bank of N.T. Butterfield & Son
NTB
$2.45B
| $331K | 0.02% |
7,231
-6,772
| -48% | -$320K |
|
Similar funds
GIM
ECM
JFL
BAM
SF
WIM
AIM
SIG
Cubist Systematic Strategies's Q2 2018 Portfolio in Review
As of Q2 2018, Cubist Systematic Strategies held 2,248 positions worth $1.99B, up 17% from $1.71B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Cubist Systematic Strategies deployed $258M of net new capital in Q2 2018, opening 441 new positions and adding to 650 existing holdings. Its largest new stake was Sage Therapeutics: 76,110 shares worth $11.9M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $59.2M trimmed.
- Cubist Systematic Strategies's largest Q2 2018 buy was Sage Therapeutics: 76,110 shares worth $11.9M.
- Cubist Systematic Strategies added most to ZENDESK INC in Q2 2018, an estimated $10.8M increase.
- Cubist Systematic Strategies's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $59.2M.
- Cubist Systematic Strategies fully exited TJX Companies in Q2 2018, selling an estimated $6.46M.
- Cubist Systematic Strategies's ten largest holdings make up 13% of its $1.99B portfolio in Q2 2018.
- Cubist Systematic Strategies opened 441 new positions and closed 492 in Q2 2018.
- Cubist Systematic Strategies's portfolio value rose 17% quarter-over-quarter to $1.99B.
Based on Cubist Systematic Strategies's 13F filing for Q2 2018, filed 14 Aug 2018.